Inhibitors of checkpoint kinases

Details for Australian Patent Application No. 2006204072 (hide)

International Classifications

Event Publications

5 July 2007 PCT application entered the National Phase

PCT publication WO2006/074207 Priority application(s): WO2006/074207

28 January 2010 Alteration of Name

The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 March 2010 Application Accepted

Published as AU-B-2006204072

8 April 2010 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 09 Mar 2010. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

29 July 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 09 Mar 2010

5 August 2010 Standard Patent Sealed

28 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.